{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:15:55Z","timestamp":1790252155833,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.vaccine.2016.12.061","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T23:02:13Z","timestamp":1484866933000},"page":"5418-5425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines"],"prefix":"10.1016","volume":"35","author":[{"given":"Yuhong","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Daniell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2016.12.061_b0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virusres.2005.04.008","article-title":"Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event","volume":"111","author":"Mueller","year":"2005","journal-title":"Virus Res"},{"issue":"7","key":"10.1016\/j.vaccine.2016.12.061_b0010","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pbio.0050183","article-title":"Imaging poliovirus entry in live cells","volume":"5","author":"Brandenburg","year":"2007","journal-title":"PLoS Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2016.12.061_b0015","doi-asserted-by":"crossref","first-page":"20709","DOI":"10.2807\/1560-7917.ES2014.19.7.20709","article-title":"Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel","volume":"19","author":"Shulman","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.12.061_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-016-0637-z","article-title":"Modeling the spread of polio in an IPV-vaccinated population: lessons learned from 2013 silent outbreak in Southern Israel","volume":"14","author":"Yaari","year":"2016","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.061_b0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/viro.1997.8450","article-title":"Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor","volume":"229","author":"Yang","year":"1997","journal-title":"Virology"},{"issue":"14","key":"10.1016\/j.vaccine.2016.12.061_b0030","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.061_b0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/oxfordjournals.aje.a112290","article-title":"Vaccine-associated poliomyelitis in the United States, 1961\u20131972","volume":"104","author":"Schonberger","year":"1976","journal-title":"Am J Epidemiol"},{"issue":"5566","key":"10.1016\/j.vaccine.2016.12.061_b0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.12.061_b0045","article-title":"Polio eradication in India: a journey from a dream to realty","volume":"2","author":"Lakhani","year":"2014","journal-title":"Int J Sci Study"},{"issue":"24","key":"10.1016\/j.vaccine.2016.12.061_b0050","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1128\/JVI.78.24.13512-13521.2004","article-title":"Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001","volume":"78","author":"Shimizu","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.12.061_b0055","first-page":"768","article-title":"Assessing the risks for poliovirus outbreaks in polio-free countries\u2013Africa, 2012\u20132013","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.12.061_b0060","first-page":"756","article-title":"Centers for Disease Control and Prevention (CDC). Assessing and mitigating the risks for polio outbreaks in polio-free countries - Africa, 2013\u20132014","volume":"63","author":"Andre","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.12.061_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nm0108-9","article-title":"Problems with the oral polio vaccine","volume":"14","author":"Bhasin","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.12.061_b0070","unstructured":"Innovation Series: How a New Method of Delivering the Inactivated Polio Vaccine Could Help Overcome Global Supply Challenges. Global Polio Eradication Initiative; 2016."},{"key":"10.1016\/j.vaccine.2016.12.061_b0075","unstructured":"Weekly Epidemiological Report, A publication of the Epidemiology Unit, Ministry of Health, Nutrition & Indigenous Medicine 2016; 43(28)."},{"key":"10.1016\/j.vaccine.2016.12.061_b0080","unstructured":"\u201cUnicef's Engagement in the Global Polio Eradication Initiative\u201d. Unicef.org."},{"issue":"11","key":"10.1016\/j.vaccine.2016.12.061_b0085","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/pbi.12575","article-title":"Cold chain and virus free chloroplast-made booster vaccine to confer immunity against different polio virus serotypes","volume":"14","author":"Chan","year":"2016","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2016.12.061_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1467-7652.2009.00479.x","article-title":"Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery","volume":"8","author":"Davoodi-Semiromi","year":"2010","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2016.12.061_b0095","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/pbi.12471","article-title":"Plant-made oral vaccines against human infectious diseases-are we there yet?","volume":"13","author":"Chan","year":"2015","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2016.12.061_b0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.12.061_b0105","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1016\/j.vaccine.2014.07.029","article-title":"Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants","volume":"32","author":"Verdijk","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.061_b0110","unstructured":"WHO. Report of a WHO informal consultation on polio neutralizing antibody assays. 1991 Geneva: World Health Organization. WHO\/EPI\/RD\/91.3, Nashville."},{"key":"10.1016\/j.vaccine.2016.12.061_b0115","unstructured":"WHO. Manual for the virological investigation of polio. 1997 WHO EPI\/GEN\/ 97.01.EPV1, Expanded Program on Immunization."},{"key":"10.1016\/j.vaccine.2016.12.061_b0120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13312-015-0610-5","article-title":"Serum IgG and IgA levels in polio and non-polio acute flaccid paralysis cases in western Uttar Pradesh, India","volume":"52","author":"Mohanty","year":"2015","journal-title":"Ind Pediatr"},{"key":"10.1016\/j.vaccine.2016.12.061_b0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/trstmh\/tru041","article-title":"Investigation of the prevalence of antibody immunodeficiency in a polio endemic area in India","volume":"108","author":"Mohanty","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.12.061_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-1157(84)80015-3","article-title":"The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years","volume":"12","author":"Nishio","year":"1984","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2016.12.061_b0135","first-page":"223","article-title":"Response of children to a single dose of oral or inactivated polio vaccine","volume":"47","author":"Magrath","year":"1981","journal-title":"Develop Biol Stand"},{"key":"10.1016\/j.vaccine.2016.12.061_b0140","article-title":"Oral tolerance induction in hemophilia B dogs fed with transplastomic lettuce","volume":"26","author":"Herzog","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.12.061_b0145","doi-asserted-by":"crossref","unstructured":"Kwon KC, Chan HT, Le\u00f3n IR, Williams-Carrier R, Barkan A, Daniell H: Codon optimization to enhance expression yields insights into chloroplast translation. Plant Physiol; 2016. http:\/\/dx.doi.org\/10.1104\/pp.16.00981.","DOI":"10.1104\/pp.16.00981"},{"key":"10.1016\/j.vaccine.2016.12.061_b0150","unstructured":"Xiao Y, Verma S, Daniell H. Oral polio booster vaccine made in edible plant cells [in preparation]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T07:24:08Z","timestamp":1536045848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16312956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0264410X16312956"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}